Joined May 2022
type1.diy retweeted
Diese Aussagen müssen viel genauer betrachtet werden! Marketing! Siehe dazu auch diese Artikel @Tims_Pants diabettech.com/cgm/welcome-t…
Abbott putting out the FUD on @dexcom . Here is the paper (pubmed.ncbi.nlm.nih.gov/3818…). N=55. They only looked at the first 24 hours when the body was still settling to insertion and neither sensor past 12 hours got a MARD less than 10% ie neither good in 1st 24hrs #ATTD2024 #dedoc
1
1
2
140
Online survey results regarding the use of AID systems (n=1588) – reveals a lot of improvement areas in AID systems, even if the users are satisfied in general. Well done! #dedoc #EASD2023
2
3
326
Main take-away of Huda Kufaishi's cohort study (n=1721): there seems to be (at least) a correlation between gastrointestinal symptoms and autonomic and peripheral neuropathy in PwD #dedoc #EASD2023
2
2
358
Main take-away of Wei Wang's resting state fMRI study of PwD (type 2): PwD with microvascular complications are more prone to cognitive impairment in comparison to PwD without microvascular complications #dedoc #EASD2023
1
2
103
@_RomanHovorka speaks of the psychosocial benefits of looping: giving people their time back, PWDs literally forgetting they have diabetes. #EASD2023 #dedoc
7
16
1,270
If you're not familiar with @CamAPS_FX this describes how it is set up. Target goes down to 4.4 mmol/L (80 mg/dL). #EASD2023 #dedoc
9
13
1,412
Novo Nordisk Foundation Diabetes Prize for Excellence - so well deserved! @_RomanHovorka #dedoc #EASD2023
78
Main take-aways of Peter Adolfsson's study: using a smart pen with bolus-advisor is improving the TIR, TAR and TBR in comparison to using a non-smart pen (for more conclusions see the slides) #dedoc #EASD2023
3
3
375
I encourage you to follow the discussion and (re-)watch the speeches here - especially when you're NOT living with diabetes: youtube.com/watch?v=mddyepJ-… #dedoc #EASD2023
3
2
274
"The most important stakeholder is the person living with diabetes" - @professorcm #EASD2023 #dedoc
9
15
600
What we wish you knew, and why: “Be mindful about what you’re posting. You take ignorance, and a smartphone, and that’s what you get.” @chelcierice on stigma and diabetes. #EASD2023 #dedoc – at Hamburg, Germany
9
18
934
Best part of the day: the #dedoc° symposium! As I'm living with diabetes myself (and aim to work in research professionally), I'm happy to see that PwD are represented at conferences like #EASD2023 not 'only' as participants but also as speakers #nothingaboutuswithoutus
1
5
6
344
@ChelcieRice talking about stigma in his workplace and stigma in social media right now - it's an impressive and emotional touching speech! So great! Thanks for that!
1
22
A map of fears and endeavors of PwD in adolescent population drawn by Timothy Jones et al. #dedoc #EASD2023
3
2
386
William Polonsky presents the new distress scale he has created which measures total distress and then identifies the components contributing: one for type 1, another for type 2. A score >2 is of clinical concern. Available at diabetesdistress.org. #EASD2022 #dedoc
1
7
16
893
A mobile app to track hypo symptoms #dedoc #EASD2023
5
6
295
Very promising approach on measuring insulin resistance in PwD via a breath test! #dedoc #EASD2023
2
2
380
Interesting groundwork of Rita Verkevisser who tries to understand the reasons behind impaired awareness of hypoglycemia (IAH) with a metabolomics approach (mainly generating hypothesis here)! #dedoc #EASD2023
2
5
382
Main take-aways of Catriona Farrell's study HIT4HYPOS regarding HIIT in type 1 diabetes: HIIT seems to be a safe form of training for PwD (post exercise hypos do not increase regarding the study), and it may even protect from nocturnal hypoglycemia. #dedoc #EASD2023
1
2
5
473
Especially interesting for PwD who are unaware of hypos in general (it was actually the goal of the study to find out if PwD and unawareness of hypos can safely do HIIT).
28